John Coleman sits down with Niklas Adamsson, CEO of Envirotainer, a global leader in temperature-controlled pharma transport. Every day, Envirotainer ships 2.5 million doses of life-saving medicines and vaccines, helping prevent the $35B lost annually due to shipment failures.

Niklas emphasizes that success in this critical industry comes down to people, processes, and technology. Proper training, clear responsibilities, and trust are key to keeping medicines safe and reaching the patients who need them.

Hosted on Acast. See acast.com/privacy for more information.

This episode explores the risks and consequences of cold chain failures, especially for

advanced therapies such as cell and gene treatments. We'll talk about how these

therapies are impacted by shipment disruptions and the importance of early cold chain

planning. The conversation will also touch on collaboration with CDMOs and logistics

providers, as well as broader reflections on where the industry needs to improve.

Hosted on Acast. See acast.com/privacy for more information.